+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Moclobemide (Ro 11-1163) vs. clomipramine in the treatment of depression: A double-blind multicenter study in Belgium



Moclobemide (Ro 11-1163) vs. clomipramine in the treatment of depression: A double-blind multicenter study in Belgium



Drug Development Research 21(4): 325-331



A multicenter study to compare the antidepressant efficacy and the tolerance of moclobemide (Ro 11-1163) to clomipramine was performed in parallel groups of patients with minor depression. The duration of the study was 6 weeks, with weekly assessments by means of Hamilton Scale of Depression (HRDS) and the Clinical Global Impression (CGl). The efficacy of moclobemide was found to be as good as that of clomipramine. The results for tolerability were possibly in favor of moclobemide.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 062114708

Download citation: RISBibTeXText

DOI: 10.1002/ddr.430210406


Related references

Moclobemide ro 11 1163 vs. clomipramine in the treatment of depression a double blind multicenter study in belgium. Drug Development Research 21(4): 325-332, 1990

Moclobemide versus clomipramine in the treatment of depression: a double-blind multicentre study in Belgium. Acta Psychiatrica Scandinavica. Supplementum 360: 50-51, 1990

Moclobemide versus clomipramine in depressed patients in general practice. A randomized, double-blind, parallel, multicenter study. Journal of Clinical Psychopharmacology 15(4 Suppl 2): 24s-30s, 1995

Multicenter double-blind randomized parallel-group clinical trial of efficacy of the combination clomipramine (150 mg/day) plus lithium carbonate (750 mg/day) versus clomipramine (150 mg/day) plus placebo in the treatment of unipolar major depression. Journal of Affective Disorders 76(1-3): 191-200, 2003

Multicenter double-blind randomized parallel-group clinical trial of effectiveness of the combination clomipramine plus lithium carbonate versus clomipramine plus placebo in the treatment of unipolar major depression. European Neuropsychopharmacology 10(Suppl. 3): S249, 2000

Moclobemide versus amitriptyline in the treatment of depression: two small double-blind multicentre studies in Belgium. Acta Psychiatrica Scandinavica. Supplementum 360: 52-53, 1990

Moclobemide versus clomipramine in endogenous depression. A double-blind randomised clinical trial. British Journal of Psychiatry 160: 519-524, 1992

Multicenter Double-Blind Study of the Efficacy of Paroxetine versus Clomipramine in Elderly Patients with Major Depression. Journal of Aging & PharmacoTherapy 13(2): 7-19, 2007

A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. Journal of Clinical Psychiatry 58(3): 112-118, 1997

A double-blind comparison of moclobemide and thioridazine versus moclobemide and placebo in the treatment of refractory, severe depression. Journal of Clinical Psychopharmacology 15(4 Suppl 2): 41s-45s, 1995

Multicenter double-blind study comparing the efficacy and tolerance of paroxetine and clomipramine in reactive depression in the elderly patient. L'Encephale 19(3): 257-261, 1993

Efficacy and safety of moclobemide compared with imipramine in the treatment of major depressive disorder. Double-blind multicenter study, Austria. Journal of Neural Transmission. Supplementum 32: 177-184, 1990

P-12-11 - Treatment of severe major depression: A double-blind study of sertraline and clomipramine. European Neuropsychopharmacology 6(Supp-S3): 123-124, 1996

Efficacy and safety of moclobemide compared with maprotiline in treatment of major depressive disorder. A double-blind multicenter study with parallel groups. Pharmacopsychiatry 26(6): 246-253, 1993

Moclobemide (Ro 11-1163) versus imipramine in the treatment of depression. Acta Psychiatrica Scandinavica. Supplementum 360: 43, 1990